Price T Rowe Associates Inc Ani Pharmaceuticals Inc Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,068 shares of ANIP stock, worth $323,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,068
Previous 5,882
3.16%
Holding current value
$323,727
Previous $375,000
3.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANIP
# of Institutions
211Shares Held
18.7MCall Options Held
11.7KPut Options Held
10.5K-
Black Rock Inc. New York, NY2.66MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$71.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY716KShares$38.2 Million0.01% of portfolio
-
State Street Corp Boston, MA704KShares$37.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$35 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $930M
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...